Skripsi

POLA KUNJUNGAN PASIEN KANKER PROSTAT SEBELUM, SAAT, DAN SESUDAH PANDEMI COVID-19 DI RSCM = PROFILE PATTERN OF PROSTATE CANCER PATIENT’S VISIT AT CIPTO MANGUNKUSUMO NATIONAL HOSPITAL IN BEFORE, DURING, AND AFTER PANDEMIC COVID-19.

Insidensi kanker prostat terus meningkat dan menempati peringkat kelima sebagai kanker paling umum pada pria. Indonesia telah menghadapi pandemi COVID-19 yang membawa tranformasi pada sistem pelayanan kesehatan, termasuk pada layanan klinik urologi di RSCM. Penelitian ini bertujuan mengetahui jumlah kunjungan pasien kanker prostat ke Poli Urologi dan karakteristik berupa usia, domisili, nilai PSA, pilihan pengobatan, derajat keganasan, dan stadium kanker prostat selama periode sebelum, saat dan sesudah Pandemi COVID-19 Penelitian menggunakan studi cross-sectional dengan rekam medis pasien. Sebanyak 380 pasien terinklusi pada kunjungan tahun 2019 – 2023. Keterbatasan data rekam medis terutama pada variabel karakteristik ditemukan pada penelitian ini. Data dilakukan metode deskriptif frekuensi SPSS Kunjungan pasien mengalami penurunan selama periode pandemi dari tahun 2019 128 pasien (33.7%), 2020 71 pasien (18.7%), 2021 63 pasien (16.6%), 70 pasien (18.4%) & 2023 48 pasien (12.6%). Pada karakteristik usia, proporsi paling banyak usia 71 – 80 tahun 152 pasien (40.8%) diikuti usia 61 – 70 tahun 123 pasien (33.0%). Domisili sebanyak 336 pasien (88.4%) berasal dari Jabodetabek. Nilai PSA pasien di atas normal yaitu 5 – 100 ng/mL sebanyak 110 pasien (41.5%) diikuti nilai PSA normal 71 pasien (26.8%). Sebanyak 90 pasien (48.6%) dengan skor Gleason derajat 5, dan 121 pasien (59.6%) dengan stadium metastasis. Profil pasien kanker prostat RSCM pada tahun 2019 – 2023 ditemukan pola kunjungan menurun dengan adanya pandemi COVID-19. Terjadi penundaan dan keterbatasan fasilitas bagi pasien berkunjung ke Poli Urologi RSCM.
Kata Kunci: kanker prostat, pandemi, covid-19


The incidence of prostate cancer continues to increase and is ranked fifth as the most common cancer in men. Indonesia has faced the COVID-19 pandemic which has brought about a transformation in the health care system, including urology clinic services at RSCM. This study aims to determine the number of prostate cancer patient visits to the Urology Clinic and characteristics in the form of age, domicile, PSA value, treatment options, degree of malignancy, and stage of prostate cancer during the period before, during and after the COVID-19 Pandemic. The study used a cross-sectional study with patient medical records. A total of 380 patients were included in the 2019-2023 visits. The limitations of medical record data are mainly in the characteristic variables found in this study. The data used the SPSS descriptive frequency method. Patient visits decreased during the pandemic period from 2019 128 patients (33.7%), 2020 71 patients (18.7%), 2021 63 patients (16.6%), 70 patients (18.4%) & 2023 48 patients (12.6%). In terms of age characteristics, the highest proportion was aged 71 - 80 years 152 patients (40.8%) followed by aged 61 -70 years 123 patients (33.0%). The domicile of 336 patients (88.4%) came from Jabodetabek. The patient's PSA value was above normal, namely 5-100 ng/mL as many as 110 patients (41.5%) followed by a normal PSA value of 71 patients (26.8%). A total of 90 patients (48.6%) with a Gleason score of grades 5, and 121 patients (59.6%) with a metastatic stage. The profile of RSCM prostate cancer patients in 2019-2023 found a decreasing visit pattern with the COVID-19 pandemic. There was a delay and limited accesbility of patients visiting the RSCM Urology Clinic.
Keywords: prostate cancer, pandemic, covid-19